ArticleFrontiers in public health2025
A taxonomy of indicators for non-communicable diseases: agreement, definition, and contextual description using diabetes as a case study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Collaborative Health Information European Framework (CHIEF) is an initiative led by the Joint Research Centre (JRC) of the European Commission to enable a sustainable data collection and production of indicators to monitor and evaluate best practices for people with NCDs. Objectives: We aimed to support international assessment and comparability of NCD indicators through a taxonomy of NCD indicators, a core set of measurable diabetes indicators and high-level policy recommendations. Materials and methods: The study is an expert review run by the multidisciplinary expert group "CHIEF-diabetes.dwg" between 2022 and 2024. The group convened on several remote and in-presence meetings. A common set of key references were identified to underpin collective discussions and agree on the fundamental criteria for the selection of indicators. An iterative process was followed to reach agreement and release final recommendations. Results: A taxonomy of NCD indicators and relevant stakeholders was identified to guide the selection process. A core set of diabetes indicators was agreed, including: diabetes incidence and prevalence rate, retinopathy prevalence rate, major lower extremity amputation incidence rate, blindness rate and rate of end stage renal disease. Measurement issues across chronic diseases and data collection were included in recommendations to the EU. Discussion: The taxonomies and core set of diabetes indicators identified by the expert group may be used as a proof of concept of a collaborative European framework. The expert group recommended: (a) to determine the purpose of NCD indicators in advance; (b) to prioritise actionable indicators for the high-level governance of chronic diseases; (c) to align with existing standardisation processes; (d) to build on the experience of existing registries; and (e) to align with current efforts to strengthen the EU data infrastructure. Conclusion: The expert group delivered general guidance on criteria and principles for the selection of NCD indicators, using diabetes as a case study. The core set of six diabetes indicators can be used as a field-test for future reporting initiatives. In this context, disease registries can provide the high-quality data needed to compute reliable indicators. Targeted projects are needed to design a cohesive health information system of NCD indicators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.